Lily NZ Case Study: Strategies for Competitive Advantage and Growth
VerifiedAdded on 2023/04/23
|4
|713
|352
Case Study
AI Summary
This case study examines Lily, a pharmaceutical affiliate in New Zealand, and its strategic response to a changing market landscape characterized by the establishment of a single pharmaceutical purchasing agency (Pharmac) focused on cost containment, increased generic competition, and patent losses. The analysis highlights the need for Lily to regain its competitive advantage by developing unique selling points, such as value-added product features, and leveraging its resources through a healthcare-related CSR campaign to enhance brand image and customer loyalty. The study suggests conducting thorough research and development to identify cost-effective product innovations and exploring partnerships with generic suppliers to manage costs. It also emphasizes the importance of market and consumer research to inform the CSR strategy and promote it effectively through media channels, ultimately aiming to improve brand awareness and financial performance.
1 out of 4









